Business

Coronary Artery Bypass Graft Devices Market: Competitive Landscape Analysis with Forecast by 2019

Press Release

Coronary Artery Bypass Graft (CABG) is most common type of heart surgery that is performed to treat people suffering from severe angina and coronary artery heart disease. In coronary heart disease, a plaque is formed inside the coronary artery that carries oxygenated blood to myocardium. As the plaque becomes harder over the time, it narrows down the artery and subsequently causes reduced blood flow to heart leading to chest pain called angina.

In CABG, a healthy artery or vein from elsewhere in the body is grafted to blocked coronary artery that facilitates the flow of oxygenated blood to heart muscles. Depending on the number of coronary arteries bypassed, the surgery is referred as single bypass, double bypass, triple bypass and quadruple bypass. Usually, there are two different methods to perform CABG namely on-pump CABG and off-pump CABG.

Obtain Report Details @ https://www.transparencymarketresearch.com/coronary-artery-bypass-graft-devices.html

Some minimally invasive coronary artery bypass (MIDCAB) surgeries are also performed such as endoscopic or thoracoscopic and robotic assisted surgery that include smaller incision, less bleeding, low risk of infection and reduced recovery time. Some of the commercially available devices used in CABG are OPTrac STILLSITE Stabilizer by Heartport, Ultima OPCAB system by Guidant and OCTOPUS 2+ Tissue Stabilization System by Medtronics. Some of the prominent vendors operating in this market are Sorin Group, Heratport, MAQUET, Guidant, Medtronic and Terumo.

Industry experts predict that the market for CABG devices will primarily be driven by increasing incidences of coronary heart disease and to some extent by the introduction of devices used in minimally invasive procedures such as da Vinci system marketed by Intuitive Surgical, Inc. Growing use of endoscopic vessel harvesting devices and anastomosis assist devices is also expected to support the growth of market.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1697

According to WHO, in 2008, approximately 17.3 million people died of cardiovascular diseases and of these around 7.3 million deaths were due to coronary heart disease. WHO also suggests that this death toll will keep on rising and will become 23.3 million by 2030. The major challenges to the market are matured market of North America and Europe and availability of minimally invasive alternative options such as percutaneous coronary interventions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: www.transparencymarketresearch.com

Tags

Related Articles

Close